0
Skip to Content
MagQu — IMR Blood Biomarker Assays
MagQu — IMR Blood Biomarker Assays
Researchers
Partnering
Patients & Families
Technology
Core Tech
Publications
Patent
Products
About
About MagQu
News & Insights
Contact
Book a meeting
MagQu — IMR Blood Biomarker Assays
MagQu — IMR Blood Biomarker Assays
Researchers
Partnering
Patients & Families
Technology
Core Tech
Publications
Patent
Products
About
About MagQu
News & Insights
Contact
Book a meeting
Researchers
Partnering
Patients & Families
Folder: Technology
Back
Core Tech
Publications
Patent
Products
Folder: About
Back
About MagQu
News & Insights
Contact
Book a meeting
Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction

Read More
Prediction of Cognitive Degeneration in Parkinson’s Disease Patients Using a Machine Learning Method
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Prediction of Cognitive Degeneration in Parkinson’s Disease Patients Using a Machine Learning Method

Read More
A Profile of Nanoparticle-Based Plasma Neurodegenerative Biomarkers for Cognitive Function Among Patients Undergoing Hemodialysis
Yiran Gan 4/8/25 Yiran Gan 4/8/25

A Profile of Nanoparticle-Based Plasma Neurodegenerative Biomarkers for Cognitive Function Among Patients Undergoing Hemodialysis

Read More
Real-time changes in the AC magnetic susceptibility of reagents during immunomagnetic reduction assays
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Real-time changes in the AC magnetic susceptibility of reagents during immunomagnetic reduction assays

Read More
Detection and assessment of alpha-synuclein in Parkinson disease
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Detection and assessment of alpha-synuclein in Parkinson disease

Read More
Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease

Read More
Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study

Read More
Diagnostic accuracy of blood biomarkers for Alzheimer's disease and amnestic mild cognitive impairment: A meta-analysis
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Diagnostic accuracy of blood biomarkers for Alzheimer's disease and amnestic mild cognitive impairment: A meta-analysis

Read More
Neurotherapy of Yi-Gan-San, a Traditional Herbal Medicine, in an Alzheimer’s Disease Model of Drosophila melanogaster by Alleviating Aβ42 Expression
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Neurotherapy of Yi-Gan-San, a Traditional Herbal Medicine, in an Alzheimer’s Disease Model of Drosophila melanogaster by Alleviating Aβ42 Expression

Read More
Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects
Yiran Gan 4/8/25 Yiran Gan 4/8/25

Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects

Read More
Newer Posts
Older Posts

News and Update

Events

Meet us at AAIC 2025
Toronto & Online | July 27–31 | Booth #1340

Location

517 Fairview Way,
Milpitas, CA 95035

Contact

info@magqu.us